Pharmacological studies with endogenous enhancer substances: β-phenylethylamine, tryptamine, and their synthetic derivatives

@article{Shimazu2004PharmacologicalSW,
  title={Pharmacological studies with endogenous enhancer substances: $\beta$-phenylethylamine, tryptamine, and their synthetic derivatives},
  author={S. Shimazu and I. Miklya},
  journal={Progress in Neuro-Psychopharmacology and Biological Psychiatry},
  year={2004},
  volume={28},
  pages={421-427}
}
  • S. Shimazu, I. Miklya
  • Published 2004
  • Medicine, Chemistry
  • Progress in Neuro-Psychopharmacology and Biological Psychiatry
The discovery of enhancer regulation in the mesencephalon and the concept that it plays a key role in the operation of innate and acquired drives [Neurochem. Res. 28 (2003) 1187] sets the trace amines (TAs) in their true physiological perspective. The regulation is defined as the existence of enhancer-sensitive neurons in the brain capable of working in a split-second on a high activity level due to endogenous enhancer substances. For the time being, only beta-phenylethylamine (PEA) and… Expand
The potential of trace amines and their receptors for treating neurological and psychiatric diseases.
  • M. D. Berry
  • Biology, Medicine
  • Reviews on recent clinical trials
  • 2007
TLDR
The aim of the current article is to review the previous studies linking trace amines to human pathology in the context of the recently discovered trace amine receptors and evidence of the existence of Trace amine receptor polymorphisms and mutations associated with such disorders. Expand
Trace amine-associated receptor 1-Family archetype or iconoclast?
  • D. Grandy
  • Biology, Medicine
  • Pharmacology & therapeutics
  • 2007
TLDR
Even though heterologously expressed TAAR1 fits the pharmacological criteria established for a bona fide TAR, a major challenge for those working in the field is to discern the in vivo pharmacology and physiology of each purported member of this extended family of GPCR. Expand
Investigation of trace amine receptors in the cardiovascular systems
Trace amines (TAs), including p-phenylethylamine (p-PEA), tyramine and octopamine are structurally and functionally related to biogenic amines such as catecholamines and serotonin and toExpand
Synephrine: from trace concentrations to massive consumption in weight-loss.
TLDR
The mechanisms involved in synephrine-induced cardiotoxicity are still unknown since studies related to its safety are scarce and this review will focus on the efficacy and toxicity aspects related to the use ofsynephrine in weight-loss. Expand
The recreational tryptamine 5-MeO-DALT (N,N-diallyl-5-methoxytryptamine): A brief review
TLDR
The case involved a man in his mid-20s who died in mid-2010 and the coroner concluded that the deceased "died from injuries sustained after being hit by a lorry whilst under the influence of 5-MeODALT". Expand
Pathogenesis of migraine: from neurotransmitters to neuromodulators and beyond
TLDR
It is believed that migraine attacks derive from a top-down dysfunctional process that initiates in a hyperexcitable and hypoenergetic brain in the frontal lobe and downstream in abnormally activated nuclei of the pain matrix. Expand
Effect of orange juice and tryptamine on the behavior and c-fos expression of Wistar rats
TLDR
The chronic and lengthy consumption of orange juice or their derivatives in the diet could be a factor responsible to induce mood disorders and may promote excess caloric consumption. Expand
Trace Amines as Intrinsic Monoaminergic Modulators of Spinal Cord Functional Systems
This chapter reports on recent observations demonstrating that the neonatal rat spinal cord contains the substrates for biosynthesis of the trace amines (TAs) β-phenylethylamine, tyramine, andExpand
Receptors of mammalian trace amines
TLDR
Observations associated with the distribution of trace amine associated receptors suggest that they may be involved in depression, attention-deficit hyperactivity disorder, eating disorders, migraine headaches, and Parkinson's disease. Expand
Receptors of Mammalian Trace Amines
The discovery of a family of G-protein coupled receptors, some of which bind and are activated by biogenic trace amines, has prompted speculation as to the physiological role of these receptors.Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 58 REFERENCES
(-)Deprenyl (selegiline), a catecholaminergic activity enhancer (CAE) substance acting in the brain.
  • J. Knoll
  • Medicine
  • Pharmacology & toxicology
  • 1998
TLDR
It may be supposed that a prophylactic low dose administration of a safe catecholaminergic activity enhancer substance during the postdevelopmental phase of life will slow the age-related decline of behavioral performances, delay natural death and decrease susceptibility to Parkinson's disease and Alzheimer's disease. Expand
Enhancer Regulation/Endogenous and Synthetic Enhancer Compounds: A Neurochemical Concept of the Innate and Acquired Drives
  • J. Knoll
  • Biology, Medicine
  • Neurochemical Research
  • 2004
TLDR
Experimental evidence and clinical data are summarized supporting the proposal that, due to the progressive decay of the mesencephalic enhancer regulation with the passing of time, the prophylactic administration of a synthetic enhancer substance during postdevelopmental life could significantly slow the age-related decay of behavioral performances, prolong life, and prevent the precipitation or delay the onset of Parkinson's disease and Alzheimer's disease. Expand
Functional interactions of 2-phenylethylamine and of tryptamine with brain catecholamines: Implications for psychotherapeutic drug action
  • A. Greenshaw
  • Medicine, Psychology
  • Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • 1989
TLDR
The possible involvement of PEA in emergent changes in beta-adrenergic receptors induced by chronic antidepressant drugs is hypothesized in relation to ongoing research. Expand
Does phenylethylamine act as an endogenous amphetamine in some patients?
TLDR
The importance of phenylethylamine in mental disorders is far from fully elucidated but the evolution of Phenylethyamine concentrations in relation to symptoms remains a worthwhile investigation for individual psychotic patients. Expand
The novel catecholaminergic and serotoninergic activity enhancer R-(−)-1-(benzofuran-2-yl)-2-propylaminopentane up-regulates neurotrophic factor synthesis in mouse astrocytes
TLDR
The results suggest that (-)-BPAP up-regulated neurotrophic factor synthesis in cultured astrocytes. Expand
Structure-activity studies leading to (-)1-(benzofuran-2-yl)-2-propylaminopentane, ((-)BPAP), a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain.
TLDR
Aiming to develop a selective CAE/SAE substance much more potent than (-)deprenyl, a series of new 1-aryl-2-alkylaminoalkanes, structurally unrelated to PEA and the amphetamines, was designed and prepared and (-)BPAP was selected as a promising candidate substance for further studies. Expand
A pharmacological analysis elucidating why, in contrast to (-)-deprenyl (selegiline), alpha-tocopherol was ineffective in the DATATOP study.
The Parkinson Study Group who conducted the Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism (DATATOP) trial designed their study in the belief that the MAO inhibitor (-)-deprenylExpand
An HPLC tracing of the enhancer regulation in selected discrete brain areas of food-deprived rats.
TLDR
A method to detect the specific enhancer effect of synthetic enhancer substances by measuring the release of transmitters from freshly isolated selected discrete brain areas (striatum, substantia nigra, tuberculum olfactorium, locus coeruleus, raphe) by the aid of HPLC with electrochemical detection is developed. Expand
Enhancer substances: selegiline and R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP] enhance the neurotrophic factor synthesis on cultured mouse astrocytes.
R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP] is a potent "catecholaminergic and serotonergic activity enhancer (CAE/SAE)", which enhances the impulse-evoked catecholamines and serotoninExpand
Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain.
TLDR
In conclusion, PEA and tyramine stimulate primarily coupling of action potential to transmitter release in the catecholaminergic neurons in the brain and displace catechlamines in higher concentration only. Expand
...
1
2
3
4
5
...